Deep Biotech companies using engineering biology for good: Moa Technology case study

MOA-logo.png

A spin-out from Oxford University, Moa Technology is developing next-generation herbicides to tackle a growing crisis in agriculture. Read more in BIA's Deep Biotech report on disruptive innovation for global sustainability.


What does the company do? 

Moa Technology is developing next-generation herbicides to tackle a growing crisis in agriculture: herbicide-resistant weeds. The company was spun out of the University of Oxford in 2017 and uses the same kind of advanced approaches employed in health and medicine-focused biotech to identify, understand and develop new herbicides, with game-changing speed and accuracy. Specifically, it is developing herbicides with novel modes of action (MOAs).

Moa-900px.png

What is the impact?

Without effective herbicides, farmers can lose up to 40% of their crop yield as a result of weed growth. This means that herbicide-resistant weeds are a major threat to global agriculture and food security.

The issue is particularly pressing because of climate change and population growth. If weeds are allowed to reduce agricultural productivity, farmers will need to use more land, fertiliser, diesel, water and other inputs to produce the same amount of food, substantially increasing carbon emissions. Increased land use for farming would also reduce natural carbon sequestration, as well as impacting biodiversity and general resilience. Furthermore, farmers will need effective herbicides to grow new crops and contend with new weed mixes as crop growing areas shift as a result of climate change.

Why is biotechnology/engineering biology the solution?

Herbicide resistance is a particularly urgent international problem given a 35-year innovation drought in the established herbicide industry, which has not delivered effective new products that can counter the problem.

Working with both synthetic molecules and natural products found in organisms and ecosystems around the world, and using a discovery engine similar to those used in drug discovery, Moa’s interdisciplinary team of scientists carry out plant-led high-throughput screening to identify new modes of action. This allows them to find whole new families of herbicides that are safer and better for the environment, and more effectively choose the best candidates for investment and development into products for farmers’ fields.

How do we drive forward the biorevolution in the UK?

The UK should make the most of its remarkable expertise in biotechnology, and in science and technology more broadly. This is in the national economic interest, and vital given international challenges and the need for innovation to address them.

Among other key priorities, the Government and other stakeholders must support and encourage the incredible talent pools in the UK, and the ecosystems around its universities. Moa illustrates these points well. Its technology was developed within the University of Oxford’s Department of Plant Sciences by a professor and his French PhD student, and today it employs an international team of more than 60 drawn from disciplines including chemistry, biotechnology, agriculture and artificial intelligence/machine learning.

What are the opportunities and challenges?

The potential for next-generation herbicides is huge, both in overcoming the immediate challenge of herbicide resistant weeds, and in providing superior performance across a range of other criteria. Moa has a prolific pipeline of both traditional and bioherbicide leads that work in new ways. Additional industry partnerships, robust yet responsive regulation, and international collaboration between governments and regulators all have a vital role to play, too.

Although Moa has strong financial backing, the challenge for governments and other stakeholders is to ensure more broadly that the UK’s cutting-edge biotechnology and research continues to be developed to support scale-up businesses that address key challenges facing the world.


 

More news and updates 

CEO Update - 1 July 2024

I will watch the General Election this Thursday with great interest, like the rest of the country, and update you on the new ministers and members of Parliament next week. You can access the policy backgrounds of the main parties and view our webinar on what the campaign has taught us about what our sector should expect from the new parliament and government.

Shaping future leaders in biomanufacturing: insights from MAC LeaP

Over the past nine years, Dr Tony Bradshaw, Managing Director of Biosocius, has collected data from three distinct projects within the biotechnology sector. This effort has yielded unique and valuable insights that can help professionals thrive and build sustainable, fulfilling careers. By analysing behavioural profiles and consulting with industry experts, we can better understand the evolving demands of leadership in bioscience.

Why digital matters for neurodegeneration treatments

Molly Andrews of the UK Dementia Research Institute, Priya Kalia of SciTribe, and Miranda Weston-Smith of BioBeat highlight the urgent need for innovative digital solutions and investments in the accurate diagnosis and effective treatment of neurodegenerative diseases, as emphasised at BioBeat24.

CEO Update - 24 June 2024

In two Newscasts time, we will know the outcome of the UK General Election to be held on Thursday, 4 July. Join our webinar tomorrow at 1 pm where we will discuss what we have learned from the campaigns and manifestoes about potential future policies and people important for our sector after the result.

CEO Update - 17 June 2024

Last week saw the key parties launch their general election manifestoes. This week sees a set piece hosting debate with the core parties talking about their approach to science and innovation at a live hustings at the Royal Society.

Life sciences in the public eye: what can we learn from the manifestoes?  

With fewer than twenty days to go and the manifestoes of the main parties now published, the BIA policy team pick apart what each party is pledging for the life science sector.

The evolving life sciences landscape

The life sciences sector in the UK has been the subject of significant attention over recent years. Activity in the sector has been spurred on by a multitude of drivers and its potential has also been frequently highlighted by the UK government.

CEO Update - 10 June 2024

UK General Election and what it might mean for the industry, including Labour's pledges on Brexit and business taxes. Upcoming events including the Cambridge Wide Open Day and the Life Science Leadership Summit. UK tech companies pitching at the London Stock Exchange and Amber Therapeutics securing $100 million in funding.

Women in Biotech Mentoring Programme: Dr Carolina Grandellis

In this interview, Dr Carolina Grandellis, Lead of the Earlham Institute Biofoundry, explores the profound impact of the BIA's Women in Biotech mentoring programme on her professional and personal life.

An urgent call for technical standards and metrics for engineering biology

There are currently very few technical standards and metrics that are specific and appropriate to the field of engineering biology. Across the innovation pipeline, there are opportunities for standards to support faster development and enable accelerated commercialisation of the bioeconomy. In response to this, an effort was undertaken with the objective of identifying key areas where standards and metrics would enable the growth of the global bioeconomy.

More within